seed
Stage
1
Investors
About
Kinomica develops a phosphoproteomic diagnostic platform to analyze protein phosphorylation patterns, enabling precision medicine by helping clinicians select effective therapies for cancer patients based on activated signaling pathways.
Explore Kinomica's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.